NAM
Nissay Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.52M | Buy |
48,677
+196
| +0.4% | +$6.1K | 0.01% | 563 |
|
|
2024
Q4 | $1.24M | Buy |
48,481
+349
| +0.7% | +$8.91K | 0.01% | 608 |
|
|
2024
Q3 | $1.36M | Buy |
48,132
+2,031
| +4% | +$57.5K | 0.01% | 602 |
|
|
2024
Q2 | $1.22M | Buy |
46,101
+1,738
| +4% | +$45.8K | 0.01% | 602 |
|
|
2024
Q1 | $1.35M | Buy |
44,363
+604
| +1% | +$18.3K | 0.01% | 586 |
|
|
2023
Q4 | $1.23M | Buy |
43,759
+2,693
| +7% | +$75.6K | 0.01% | 582 |
|
|
2023
Q3 | $1.11M | Buy |
41,066
+1,871
| +5% | +$50.8K | 0.01% | 587 |
|
|
2023
Q2 | $1.2M | Buy |
39,195
+2,235
| +6% | +$68.7K | 0.01% | 565 |
|
|
2023
Q1 | $1.33M | Sell |
36,960
-1,254
| -3% | -$45.2K | 0.01% | 531 |
|
|
2022
Q4 | $1.51M | Sell |
38,214
-321
| -0.8% | -$12.7K | 0.01% | 497 |
|
|
2022
Q3 | $1.55M | Buy |
38,535
+1,708
| +5% | +$68.6K | 0.02% | 474 |
|
|
2022
Q2 | $1.55M | Buy |
36,827
+89
| +0.2% | +$3.74K | 0.02% | 482 |
|
|
2022
Q1 | $1.43M | Buy |
36,738
+1,023
| +3% | +$39.8K | 0.01% | 549 |
|
|
2021
Q4 | $1.42M | Buy |
35,715
+16,761
| +88% | +$668K | 0.01% | 567 |
|
|
2021
Q3 | $685K | Buy |
18,954
+824
| +5% | +$29.8K | 0.01% | 675 |
|
|
2021
Q2 | $743K | Buy |
18,130
+201
| +1% | +$8.24K | 0.01% | 678 |
|
|
2021
Q1 | $782K | Buy |
17,929
+5,056
| +39% | +$221K | 0.01% | 652 |
|
|
2020
Q4 | $644K | Buy |
+12,873
| New | +$644K | 0.01% | 649 |
|